Arca
Skip to content
Tools
Tools

Infertility

Drug research and approvals for infertility: what is recruiting, what Health Canada authorized, FDA orphan designations and EU medicines. See every condition.

As of Nov 21, 2026, 280 studies of infertility are recruiting on ClinicalTrials.gov, Health Canada has authorized 11 drug trials for it since 2013, FDA has 1 approved and 3 open orphan designations naming it, and the EU has 2 authorised medicines for it.

  • Recruiting worldwide: 280
  • Trials authorized in Canada: 11
  • FDA orphan approvals: 1
  • EU medicines: 2

Recruiting now

Newest posted first, of 280 recruiting on ClinicalTrials.gov ↗

Drug pipeline

Each drug at the furthest stage it has reached for this condition, from ChEMBL's drug indications

Approved 4

Phase 3 12 of 39

Phase 2 12 of 20

Phase 1 or earlier 10

How its trials ended

2,437 ClinicalTrials.gov studies of the condition, classified by TrialPanorama, partly automatically, so some labels are wrong

Of the 421 whose ending is known, 30% met their primary endpoint, 12% missed it and 58% stopped early.

  • Completed, result not reported1,03542%
  • Status unknown54822%
  • Ongoing43318%
  • Stopped: other or unclear1406%
  • Met its primary endpoint1255%
  • Stopped: enrollment or feasibility783%
  • Missed its primary endpoint512%
  • Stopped: lack of efficacy141%
  • Stopped: sponsor or business decision8<1%
  • Stopped: funding4<1%
  • Stopped: safety1<1%

Trials authorized in Canada

The 10 newest of 11; search them all in Canada trials
Apr 16, 2025Menopur and rekovelle combination study version 2.0Rekovelle (follitropin delta) / Menopur (menotropins)Estée Lauder CompaniesOngoing
Sep 13, 2023Fsh and lh versus fsh alone for ovarian stimulation in non-hormone sensitive onco-fertility patients: a randomized controlled trialGonal-f pen / LuverisMount Sinai HospitalPending
Mar 15, 2023A phase 3, multicenter, randomized, double-blind, double-dummy, activecontrolled, non-inferiority study to investigate the efficacy and safety of a single…OG-8962 (corifollitropin alfa) / Follitropin beta 600 IU/0.72ML / Leuprolide…OrganonPending
Mar 15, 2023A phase 3, multicenter, randomized, double-blind, double-dummy,activecontrolled, non-inferiority study to investigate the efficacy and safety of a single…OG-8962 (corifollitropin alfa) / Follitropin beta 600 IU/0.72ML /leuprolide…OrganonPending
Sep 9, 2022Rescue progesterone supplementation in patients with low progesterone on the day of embryo transfer for modified natural cycles: a non-inferiority studyProgesterone / Acetylsalicylic acidEstée Lauder CompaniesClosed
Apr 1, 2021Probiotic and antibiotic therapies in women with unexplained infertilityMetronidazoleMcMaster UniversityOngoing
Feb 19, 2021Bariatric surgery for fertility-sparing treatment of atypical hyperplasia and grade 1 cancer of the endometrium (b-fierce)LevonorgestrelUniversity Health NetworkOngoing
Jul 5, 2019Effect of personalized dosages of rekovelle on the number of mature follicles reached in intra-uterine inseminationRekovelle (follitropin delta) / Endometrin (progesterone effervescent vaginal…Estée Lauder CompaniesPending
Mar 28, 2018A pilot phase II, multicentre, open-label, randomized, controlled study of the efficacy and safety of controlled ovarian stimulation with fixed induction timeLuveris / Gonal-f / EstraceThe Montreal Fertility CenterClosed
Oct 6, 2015Dopamine D-2 antagonist use in poor responders in ivf: a randomized controlled trialMetoclopramideToronto Centre for Advanced Reproductive TechnologyPending

FDA orphan designations

Approved first, then open designations, newest first
May 24, 2000Gonal-FFor the induction of spermatogenesis in men with primary and secondary hypogonadotropic hypogonadism in whom the cause of infertility is…EMD Serono, Inc.Approved
Feb 1, 2019Autologous adult bone marrow-derived and unexpanded CD133+…Treatment of women with infertility and a thin endometrium seeking pregnancyAsherman Therapy S.L.U.Designated
Feb 13, 1990Sermorelin acetateAdjunct to gonadotropin therapy in the induction of ovulation in women with anovulatory or oligo-ovulatory infertility who fail to ovulate…EMD Serono, Inc.Designated
Sep 1, 1987SomatropinAdjunct for the induction of ovulation in women with infertility due to hypogonadotropic hypogonadism or bilateral tubal occlusion or…Novo Nordisk PharmaceuticalsDesignated

Medicines authorised in the EU

Newest first
Jun 25, 2007PergoverisFollitropin alfa; lutropin alfaMerck Europe B.V.EMA ↗
May 2, 1996PuregonFollitropin betaOrganon N.V.EMA ↗

Condition names come from Health Canada's trial database. Orphan designations and EU medicines are matched when their indication names the condition as whole words, so a broader or differently worded indication can be missed. Recruiting counts are live from ClinicalTrials.gov's own condition search, refreshed daily. ClinicalTrials.gov, Health Canada Clinical Trials Database, FDA orphan designations, EMA

Esc

Type a name: a tool, a company, a drug or brand, a condition, a gene or a state. Identifiers like K231234, NCT05012345 or NDA 215866 open their record.

Logos are each company's own site icon, matched by name through Wikidata, or logos provided by Logo.dev.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.